arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CAPRICOR THERAPEUTICS, INC.

CAPR

$9.34 ▲ +0.44 (+4.94%) at close

21 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CAPRICOR THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $434.1M

Dividend Yield —

Revenue Growth N/M

Op. Margin None

ROIC -35.4% ↘

FCF / Share $-1.56 ↘

Trailing P/E —

Price / Book 1.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 22, 2026.

21-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-105.04M

↓ -159.6% —

Operating Margin Operating profit as % of sales

-191.1%

↓ -99.9% —

FCF / Share Free cash flow per share

$-1.56

↓ -33.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Revenue Growth YoY (%)	N/M	-11.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-244%)	886.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10985%)	941.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11673%)	-21.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-363%)	-69.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-964%)	-39.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-598%)	-37.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-566%)	-33.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-516%)	-27.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-444%)	15.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+91%)	851.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10540%)	-75.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1040%)	50.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+525%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	-96.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-38.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	29.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-35.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	1.1% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-159.6% Weak ↓ Weak Declining Year-over-year change in net income	-81.6% Weak ↓ Weak Declining Year-over-year change in net income	23.2% Good ↑ Good Improving Year-over-year change in net income	-44.9% Weak ↓ Weak Declining Year-over-year change in net income	-46.6% Weak ↓ Weak Declining Year-over-year change in net income	-78.7% Weak Weak Year-over-year change in net income	49.7% Excellent Excellent Year-over-year change in net income	N/M	N/M	-46.3% Weak ↓ Weak Declining Year-over-year change in net income	-106.8% Weak ↑ Weak Improving Year-over-year change in net income	30.1% Excellent ↑ Excellent Improving Year-over-year change in net income	81.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-856.2% Weak ↓ Weak Declining Year-over-year change in net income	19.0% Good ↑ Good Improving Year-over-year change in net income	23.4% Good ↑ Good Improving Year-over-year change in net income	-1147.9% Weak ↓ Weak Declining Year-over-year change in net income	35.6% Excellent Excellent Year-over-year change in net income	16.4% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	-33.9% Weak Weak Year-over-year change in free cash flow	-16.3% Weak Weak Year-over-year change in free cash flow	N/M	N/M	-14.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	63.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	61.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	21.6% Good Good Year-over-year change in free cash flow	22.1% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	349.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	332.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	36.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-47.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-51.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-36.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-32.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-17.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	99.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	39.5% Excellent Excellent Compound annual revenue growth over 3 years	52.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	85.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	72.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-0.9% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-42.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-43.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-26.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	27.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	5.6% Fair Fair Compound annual revenue growth over 5 years	24.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Operating Margin (%) (%)	—	-191.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1374%)	-95.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-738%)	—	—	—	—	—	-482.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3316%)	-424.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2930%)	-228.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1624%)	-125.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-938%)	—	—	-361.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2511%)	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	-181.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1614%)	-88.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-838%)	—	—	—	—	—	91.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+660%)	-470.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4019%)	-233.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2042%)	-129.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1182%)	—	—	-360.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3105%)	—	—	—	—	—	—
FCF Margin (%) (%)	—	-184.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-106.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	114.3% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-366.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-343.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-5.87x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Return on Invested Capital (%)	-35.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-84.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-199.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-89.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-262.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-90.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	335.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	965.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	76.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1019.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	22156.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-465.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-191.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-30.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-165.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-79.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-90.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-78.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-124.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20667.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-357.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-171.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-34.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-27.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-98.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-757%)	-246.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1741%)	-63.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-526%)	-48.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-111.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-845%)	—	21.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+44%)	—	—	99.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+563%)	—	—	—	-232.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1648%)	-264.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1860%)	-249.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1765%)	-113.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-856%)	-63.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-525%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	-32.25x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-49.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-50.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-30.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-118.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	-36.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-287.85M	$-11.29M	$-14.69M	$-9.60M	$-34.89M	$-32.67M	$-3.90M	$-4.26M	$-6.14M	$-3.20M	$-5.57M	$-8.03M	$-1.73M	$-46.72K	$-1.04M	$-3.38M	$-3.18M	—	—	—	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Revenue per Share (USD)	$0.00	$0.63	$0.94	$0.10	$0.01	$0.02	$0.27	$0.57	$1.15	$2.16	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-2.26	$-1.15	$-0.83	$-1.18	$-0.87	$-0.88	—	—	—	$-10.10	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.56	$-1.17	$-1.00	$0.12	$-0.78	$-0.68	$-1.84	$-4.82	$-6.15	$-7.90	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.33	$3.19	$0.73	$0.47	$1.30	$1.37	$1.31	$1.47	$4.27	$-1.87	$-0.63	$-5.34	$-0.46	$-0.04	$0.21	$0.75	—	—	—	—	—
Tangible Book Value per Share (USD)	$5.33	$3.19	$0.73	$0.47	$1.30	$1.37	$1.31	$1.47	$4.27	$-1.87	$-0.63	$-5.34	$-2.10	$-0.04	$0.21	$0.75	—	—	—	—	—
Basic Weighted Avg Shares (shares)	46.48M	35.22M	26.78M	24.55M	23.09M	15.57M	3.71M	2.94M	2.32M	1.86M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Working Capital (USD)	$287.10M	$142.36M	$19.59M	$19.30M	$32.30M	$30.71M	$9.65M	$7.22M	$14.04M	$13.21M	$7.46M	$5.31M	$1.63M	$-159.35K	$769.04K	$2.53M	—	—	—	—	—
Total Equity (USD)	$305.79M	$145.46M	$22.60M	$11.79M	$31.37M	$28.20M	$6.84M	$4.62M	$11.23M	$-4.00M	$-1.03M	$-6.25M	$-534.88K	$-167.31K	$830.72K	$2.60M	$2.98M	$252.55K	$863.17K	$1.84M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Jul 4, 2005 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$22.27M	$25.18M	$2.55M	$244.90K	$310.25K	$1.01M	$1.67M	$2.67M	$4.00M	$5.52M	$4.79M	$503.23K	$2.03M	$1.35M	—	—	—	—	—	—
Depreciation Expense (USD)	$1.89M	$1.43M	$1.07M	$533.13K	$245.70K	$143.89K	$171.96K	$157.65K	$144.17K	$125.72K	$110.86K	$41.90K	$26.92K	$326.90K	$7.51K	$12.93K	—	—	—	—	—
Net Income, GAAP (USD)	$-105.04M	$-40.47M	$-22.29M	$-29.02M	$-20.02M	$-13.66M	$-7.64M	$-15.19M	$2.43M	$-18.81M	$-12.86M	$-6.22M	$-8.89M	$-46.71M	$-4.88M	$-6.03M	$-7.87M	$-630.86K	$-979.08K	$-1.17M	—
Operating Cash Flow (USD)	$-69.81M	$-40.00M	$-25.60M	$4.92M	$-16.81M	$-10.05M	$-6.82M	$-13.86M	$-14.23M	$-14.45M	—	—	—	$-34.89M	$-4.65M	$-4.32M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 21 years · 81 quarters

CAPRICOR THERAPEUTICS, INC.

Analytical Summary

21-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CAPR with peers